跳至主要内容
临床试验/NCT03930979
NCT03930979已完成不适用

The Effect of Hyperoxia on Cardiac Output in Patients Undergoing Procedural Sedation in the Emergency Department.

Medical Centre Leeuwarden1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
The change in cardiac output (L/min) after respectively 15L/min and flush rate preoxygenation in respect to baseline

研究概览

简要总结

Rational: Preoxygenation is a standard procedure before (deep) sedation in the ED. However, there is literature suggesting that too much oxygen can be harmful. One potential detrimental effect is a decrease in cardiac output due to coronary vasoconstriction. So far, it is unknown if this effect is rate dependent and if it also occurs after only a short period of hyperoxia, as patients experience during procedural sedation pre-oxygenation.

Objective: To investigate if hyperoxia has a negative effect on Cardiac index (CI) in patients undergoing procedural sedation in the ED.

详细描述

Methods: In patients needing sedation for a painful condition, non-invasive measurements of CI, stroke volume and total peripheral resistance are performed using the Clearsight non-invasive cardiac output monitoring system.. Measurements will be taken at baseline, after 1,2 and 5 minutes of 15L O2/min, and then after another 2 and 5 minutes of flush rate oxygen and during the subsequent sedation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting in the ED of the Medical Center Leeuwarden (MCL) who have a painful condition for which procedural sedation is required.

排除标准

  • - Cardiogenic shock (SBP<90 mmHg)
  • Procedural sedation for cardioversion
  • Pregnancy
  • General contra-indications for the procedural sedation according to local sedation protocol of the MCL.
  • Hypoxia (sat <90% or pO2 <8)) despite oxygen suppletion
  • Age < 18 years
  • Non-invasive ventilation (NIV) or intubation
  • No informed consent
  • Use of bleomycin
  • COPD GOLD III of IV
  • COPD GOLD I of II with hypercapnia (PCO2 > 6,4 kPa)
  • Patients in whom no reliable signal for Clearsight measurement can be obtained

结局指标

主要结局

The change in cardiac output (L/min) after respectively 15L/min and flush rate preoxygenation in respect to baseline

时间窗: at baseline, at 1,2,5 (15L),7 and 10 minutes (flush o2)

Cardiac output is measured by Clearsight non invasive hemodynamic monitoring system; 3 baseline measurements are done separated by one minute intervals; subsequently 15L/min O2 is started. After 1,2 and 5 minutes, measurements are repeated. After 5 minutes, flush rate O2 is started. After 2 and 5 minutes, measurements are repeated.

次要结局

  • The change in heart rate (BPM) after respectively 15L/min and flush rate preoxygenation in respect to baseline(at baseline, at 1,2,5, (15L o2) and 7, 10 minutes (flush o2))
  • the change in systolic blood pressure (mmHg) after respectively 15L/min and flush rate preoxygenation in respect to baseline(at baseline, at 1,2,5 (15L o2) and 7, 10 minutes (flush o2))
  • The change in stroke volume (ml) after respectively 15L/min and flush rate preoxygenation in respect to baseline(at baseline, at 1,2,5 (15L o2) and 7, 10 minutes (flush o2))
  • the change in total peripheral vascular resistance after respectively 15L/min and flush rate preoxygenation in respect to baseline(at baseline, at 1,2,5 (15L o2) and 7,10 minutes (flush o2))
  • The relation of the difference in CI with the occurrence of of haemodynamic sedation events(at baseline, at 1,2,5 (15L o2) ,7 and 10 minutes (flush o2))

研究者

发起方
Medical Centre Leeuwarden
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Effect of Hyperoxia on Cardiac Output | 临床试验